The future of rare diseases and orphan drugs

 

World Orphan Drug Congress

  • Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.
     
  • Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups.
     
  • Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs. 
     
  • Network with attendees of our co-located World Gene Therapy Congress. 

Download the brochure

 

Should you sponsor?

Why get involved?

Find out more about how you can promote your products at the orphan drug sector’s premier event by downloading the sponsorship brochure today. 

"WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford PharmaGenesis

Why sponsor?

  • Speak to a room full of orphan drug experts
  • Host a roundtable and meet your customers
  • Let us organise 1-2-1 meetings for you
  • Let us generate sales leads pre-event
  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Educate your target market
  • Generate new sales leads
  • Raise brand profile

Get the sponsorship brochure

2015 sponsor & exhibitors

 

  • Gold Sponsor

    PTC Therapeutics at World Orphan Drug Congress

    Gold Sponsor

    Quintiles at World Orphan Drug Congress
  • Silver Sponsor

    Alliance Life Sciences Consulting Group at World Orphan Drug Congress

    Silver Sponsor

    Mapi at World Orphan Drug Congress
  • Associate Sponsor

    Durbin Plc at World Orphan Drug Congress

    Associate Sponsor

    Genpharm Services at World Orphan Drug Congress
  • Associate Sponsor

    Voisin Consulting Life Sciences at World Orphan Drug Congress

    Associate Sponsor

    Ergomed at World Orphan Drug Congress
  • Exhibitor

    Comradis at World Orphan Drug Congress

    Exhibitor

    Cote Orphan Consulting at World Orphan Drug Congress
  • Exhibitor

    Orphan Reach at World Orphan Drug Congress

    Exhibitor

    Oxford PharmaGenesis at World Orphan Drug Congress

Join them

 

Interactive Sessions Offer High Level Networking

 

World Orphan Drug Congress

“WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford Pharmagenesis

World Orphan Drug Congress

“Well organised, good programme and most useful, the networking sessions.”
AlepSyr Biotech Consultancy

World Orphan Drug Congress

“The event was excellent for networking and gathering information.”
Ataxia South Wales

 

Be part of the conversation

 

korea-flag

Korea’s Orphan Drug Pricing Policy Changes for the Better

Despite incentives for development Korea remains dependant on imported orphan drugs Korea is one of the few countries within the APAC region which already has an implemented legislation for promoting orphan drugs research and development. The active patient community led by the Korea Organization for Rare Disease (KORD), lobbying amongst hospitals, and advanced clinical and […]
October FDA Orphan Drug Designations

FDA Orphan Drug Designation – November 2014

Find the EMA’s orphan designation and approvals for November here. Find the FDA’s October designations here. FDA - 13/11/2014 Generic Name: stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells Trade Name: Nicord(R) Orphan Designation: Treatment of Hodgkin lymphoma Orphan Designation Status: Designated FDA Orphan Approved: Sponsor: Gambia Cell FDA - 13/11/2014 Generic Name: stem/progenitor […]
o-GENE-THERAPY-facebook

Pfizer Enters the Gene Therapy Ring with Spark Therapeutics Tie-in

Pfizer has entered the gene therapy ring with the hiring of Professor Michael Linden, University College London, and deal with Spark Therapeutics Pfizer has announced two strategic decisions to increase their investment in rare disease research and development. To get the ball rolling, Pfizer have established an agreement with Spark therapeutics incorporating Spark’s own gene […]

Join the Community

Strategy and innovation for the orphan drug and rare disease industry

Sign Up to Our Newsletter